GLG Life Tech Corporation Announces FDA Issuance of Two Letters of no Objection for BlendSure(TM) and PureSTV(TM) Stevia Extract
July 18 2011 - 5:30AM
GLG Life Tech Corporation (Nasdaq:GLGL) (TSX:GLG) ("GLG" or the
"Company"), the vertically-integrated leader in the agricultural
and commercial development of high quality stevia and all natural
and zero calorie food and beverage products, announces the United
States Food and Drug Administration ("FDA") has issued a Generally
Recognized as Safe (GRAS) Letter of No Objection & GRN000349)
for GLG's high purity stevia extracts: PureSTVā¢ (Filing No.
GRN000348) and BlendSureā¢ (Filing No. GRN000349). These high purity
extracts both contain greater than 95% steviol glycosides.
The GRAS process is a legal and FDA-approved process that allows
companies to conduct their own GRAS determinations by consulting
with an independent panel of scientists to determine if an
ingredient meets the FDA's criteria for safety. To ensure even
further confidence in its products, GLG has submitted its two
dossiers to the FDA for review which has resulted in these Letters
of No Objection. In addition, GLG has also recently filed a notice
with the FDA following self affirmation for its RA 95 high purity
stevia extract (Filing No. GRN 380).
Dr. Luke Zhang, Chairman and CEO of GLG stated, "We have
received the first Letter of No Objection of RA 97 in 2010 and this
milestone marks the second and third Letters of No Objection that
GLG has received from the FDA and it affirms our long-term
commitment to provide our customers with the highest quality
standards of stevia extracts in the United States and around the
world. RA (rebaudioside A) and STV (stevioside) are the two
major components from the stevia plant and the GLG R&D and
production teams have been working on know how technologies and
patents to produce both high purity RA and STV stevia extracts
since 2001. We have also found that the combination of high purity
RA and STV together tastes better than either high purity RA or
high purity STV on their own in many beverage and food
applications. GLG developed a unique product named BlendSureTM
made by the combination of high purity RA stevia extract and high
purity STV extract. The three letters from the FDA makes GLG the
first and only company in the world which can produce high purity
of RA, STV and BlendSureTM, and has received all of the
corresponding Letters of No Objection from the FDA for these
products. I am very pleased that the three letters will allow our
RA, STV and BlendSureTM to be utilized in many of our AN0CTM
beverage and foods. We have found that the FDA GRAS standard is
respected in many of our key international markets including China
and we will therefore be able to further leverage this major
achievement in our international markets."
About GLG Life Tech Corporation
GLG Life Tech Corporation (Nasdaq:GLGL) (TSX:GLG) is a global
leader in the supply of high purity stevia extracts, an all
natural, zero-calorie sweetener used in food and beverages. The
Company's vertically integrated operations cover each step in the
stevia supply chain including non-GMO stevia seed breeding, natural
propagation, stevia leaf growth and harvest, proprietary extraction
and refining, marketing and distribution of finished product. GLG's
advanced technology, extraction technique and premier, high quality
product offerings make it a leading producer of high purity, great
tasting stevia extracts. For further information, please visit
www.glglifetech.com.
The GLG Life Tech Corporation logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=7994
Forward-looking statements:This press release
contains certain information that may constitute "forward-looking
information" and "forward-looking statements" within the meaning of
applicable Canadian and United States securities laws. All
statements relating to plans, strategies, projections of results of
specific activities or investments, and other statements that are
not descriptions of historical facts may be forward-looking
statements. Forward-looking statements and information are
inherently subject to risks and uncertainties, and actual results
could differ materially from those currently anticipated due to a
number of factors, which include, but are not limited to,
operational risks, the effects of general economic conditions,
changing foreign exchange rates and actions by government
authorities, uncertainties associated with legal proceedings and
negotiations, industry supply levels, competitive pricing pressures
and other risks and uncertainties disclosed in the public documents
filed by the Company with Canadian and United States securities
regulatory authorities. Forward-looking statements and information
may be identified by terms such as "may", "will", "should",
"continue", "expect", "anticipate", "estimate", "believe",
"intend", "plan" or "project", or similar terms or the negatives of
these terms. Although we believe that the expectations reflected in
the forward-looking statements and information are reasonable, we
cannot guarantee future results, levels of activity, performance,
or achievements. The Company's forward-looking statements and
information reflect the beliefs, opinions and projections on the
date the statements are made. The Company assumes no obligation to
update forward-looking information should circumstances or
management's estimates or opinions change, except as required by
law.
CONTACT: Sophia Luke
Vice President of Investor Relations
GLG Life Tech Corporation
+1 (604) 669-2602 Ext 104
ir@glglifetech.com
Glg Life Tech Corp (MM) (NASDAQ:GLGL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Glg Life Tech Corp (MM) (NASDAQ:GLGL)
Historical Stock Chart
From Jul 2023 to Jul 2024